Loading…
Antibiotic prophylaxis in clean‐contaminated head and neck cases with microvascular free flap reconstruction: A systematic review and meta‐analysis
Background Optimal antibiotic prophylaxis duration in head and neck clean‐contaminated free‐flap cases is unknown. Methods A systematic review/meta‐analysis was conducted using PubMed/MEDLINE, Cochrane Library, Web‐of‐Science, and Scopus databases. Results Of the 3755 searched articles, 5 articles w...
Saved in:
Published in: | Head & neck 2018-02, Vol.40 (2), p.417-427 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Optimal antibiotic prophylaxis duration in head and neck clean‐contaminated free‐flap cases is unknown.
Methods
A systematic review/meta‐analysis was conducted using PubMed/MEDLINE, Cochrane Library, Web‐of‐Science, and Scopus databases.
Results
Of the 3755 searched articles, 5 articles were included for a total of 861 patients. The recipient surgical site infection risk was significantly higher in patients receiving prophylactic antibiotics for ≤24 hours compared to >24 hours (relative risk [RR] 1.56; 95% confidence interval [CI] 1.13‐2.14). In the post hoc multivariate analysis based on available individual‐level data on 697 patients from 3 studies, the risk of surgical site infection for ≤24 hours versus >24 hours was not significant after adjusting for antibiotic type (RR 1.09; 95% CI 0.78‐1.55). When compared to ampicillin‐sulbactam, patients who received clindamycin prophylaxis had an increased likelihood of recipient surgical site infection (RR 2.85; 95% CI 1.95‐4.17).
Conclusion
Less than or equal to 24 hours of antibiotic prophylaxis in head and neck clean‐contaminated free‐flap is likely sufficient but a strong conclusion remains elusive. Clindamycin prophylaxis increases the risk of recipient surgical site infection. Further prospective trials are necessary to clarify. |
---|---|
ISSN: | 1043-3074 1097-0347 |
DOI: | 10.1002/hed.24988 |